RETISPEC
RetiSpec is developing a non-invasive eye scanner for early detection of Alzheimer’s Disease pathology years before symptoms occur, so that clinicians can intervene with emerging therapeutics early, when there’s a chance of actually impacting the disease.
RETISPEC
Industry:
Health Care Medical Device
Founded:
2016-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.retispec.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
750 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Microsoft Azure DNS GStatic Google Static Content Google Cloud
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Employees Featured
Founder
Investors List
iGan Partners
iGan Partners investment in Seed Round - RetiSpec
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation investment in Grant - RetiSpec
NEXT Canada
NEXT Canada investment in Pre Seed Round - RetiSpec
MassChallenge
MassChallenge investment in Non Equity Assistance - RetiSpec
Official Site Inspections
http://www.retispec.com Semrush global rank: 8.79 M Semrush visits lastest month: 257
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "RetiSpec"
RetiSpec | Alzheimer's disease eye scan | Toronto
Our mission is to enable widespread early and accurate detection of neurodegenerative disease markers with accessible, affordable and scalable AI-driven retinal imaging. To achieve this …See details»
RetiSpec - LinkedIn
RetiSpec is an AI-based company focused on early detection of neurodegenerative diseases through a simple eye exam. RetiSpec's proprietary AI solution leverages existing retinal imaging...See details»
Solution | RetiSpec
RetiSpec is a medical imaging company using advanced Artificial Intelligence to develop a screening tool for early and accurate detection of Alzheimer’s disease markers in the eye. We use advanced imaging technology to detect disease …See details»
RetiSpec - Crunchbase Company Profile & Funding
RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer’s Disease pathology. View contacts for RetiSpec to access new leads and connect with decision-makers.See details»
Toronto startup’s eye test tool could catch Alzheimer’s …
Aug 29, 2023 · Using a hyperspectral sensor in a standard optometrist’s camera, RetiSpec’s platform uses proprietary AI algorithms to detect and measure amyloid proteins, a key marker of the disease, in a routine retinal scan that lasts mere …See details»
RetiSpec Inc. | Alzheimer's Drug Discovery Foundation
Jul 7, 2023 · RetiSpec has developed its rHSI system to provide prognostic information regarding an individual’s likely PET brain amyloidosis status (PET positive or negative) to aid in the …See details»
Retispec’s innovative AI technology transforming Alzheimer’s …
Jul 31, 2023 · The feature showcased an initiative led by the Davos Alzheimer’s Collaborative to assess the feasibility of utilizing RetiSpec’s AI technology in community-based settings for …See details»
RetiSpec Closes $10M USD to Advance Commercialization of its AI …
Aug 7, 2024 · RetiSpec Inc., an innovator in AI-driven eye diagnostics for brain health, recently announced the successful closing of its $10M USD Series A financing. This funding will enable …See details»
RetiSpec’s AI-Driven Eye Test Detects Alzheimer’s Early
Jul 18, 2024 · RetiSpec has created a completely non-invasive process that uses eye imaging to detect Alzheimer’s disease. They leverage already existing equipment – the fundus camera that can be found in any eye doctor's office – …See details»
RetiSpec Inc. | Alzheimer's Drug Discovery Foundation
Sep 13, 2019 · We propose to use early retinal changes as a biomarker to identify individuals with preclinical and symptomatic Alzheimer’s disease, facilitating therapeutic interventions before …See details»
RetiSpec Company Profile 2024: Valuation, Funding
Developer of an AI-driven retinal imaging technology intended for early Alzheimer's detection. The company's technology utilizes a simple eye exam to identify neurodegenerative disease markers, enabling healthcare providers to …See details»
RetiSpec funded to accelerate Alzheimer’s detection tech
Oct 16, 2019 · RetiSpec Inc. is a medical imaging company developing a tool for the early detection of Alzheimer’s disease biomarkers in the eye using machine learning. RetiSpec’s …See details»
RetiSpec & Topcon Healthcare Join Forces for Eye Diagnostic Tool
Apr 30, 2024 · RetiSpec’s clinically validated eye diagnostic AI aims to help healthcare providers predict amyloid burden, a core biomarker of Alzheimer’s disease even before symptoms emerge.See details»
RetiSpec Closes Series A for AI-Driven Early Alzheimer's Eye Test ...
Jul 30, 2024 · RetiSpec’s $10M Series A financing will enable the StartUp Health company to accelerate the commercialization of its groundbreaking technology aimed at early detection of …See details»
RetiSpec Closes $10 Million to Advance Commercialization of its AI ...
Jul 29, 2024 · TORONTO— RetiSpec Inc., an innovator in AI-driven eye diagnostics for brain health, has announced the successful closing of its $10 million Series A financing. This …See details»
Toronto's RetiSpec pushes frontier of Alzheimer's detection with ...
Sep 5, 2024 · RetiSpec’s technology takes finely detailed images of a patient’s retina, the structure at the back of the eye that detects light and sends the signals back to the brain. The …See details»
RetiSpec Closes $10M USD to Advance Commercialization of its AI …
Jul 26, 2024 · RetiSpec is a Toronto -based medical AI company that aims to enable widespread early and accurate detection of neurodegenerative disease markers through a simple eye …See details»
RetiSpec Receives Award from Alzheimer's Drug ... - Markets Insider
Oct 8, 2019 · RetiSpec Inc. is a medical imaging company developing a tool for the early detection of Alzheimer's disease biomarkers in the eye using machine learning. RetiSpec's …See details»
RetiSpec: A Novel Retina Scanner for Diagnosing Dementia
We are studying the accuracy of a non-invasive eye scanner called RetiSpec in detecting the presence of amyloid beta. We are also assessing the feasibility and acceptability of …See details»
RetiSpec aims to improve lives—and the healthcare system
The CABHI-funded RetiSpec trial will determine the safety and effectiveness of the technology through human clinical testing, and help spur commercialization of the technology in Ontario …See details»